182 related articles for article (PubMed ID: 2206033)
1. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
Am J Cardiol; 1990 Sep; 66(8):22B-30B. PubMed ID: 2206033
[TBL] [Abstract][Full Text] [Related]
2. Effects of simvastatin and probucol in hypercholesterolemia (Simvastatin Multicenter Study Group II).
Pietro DA; Alexander S; Mantell G; Staggers JE; Cook TJ
Am J Cardiol; 1989 Mar; 63(11):682-6. PubMed ID: 2646895
[TBL] [Abstract][Full Text] [Related]
3. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
Helve E; Tikkanen MJ
Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
[TBL] [Abstract][Full Text] [Related]
4. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
[TBL] [Abstract][Full Text] [Related]
5. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
Forti N; Ramires JA
Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
[TBL] [Abstract][Full Text] [Related]
6. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia.
Bradford RH; Shear CL; Chremos AN; Dujovne C; Franklin FA; Hesney M; Higgins J; Langendörfer A; Pool JL; Schnaper H
Am J Cardiol; 1990 Sep; 66(8):44B-55B. PubMed ID: 2206036
[TBL] [Abstract][Full Text] [Related]
7. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027
[TBL] [Abstract][Full Text] [Related]
8. Probucol in hypercholesterolemia. A double blind study.
Riesen WF; Keller M; Mordasini R
Atherosclerosis; 1980 Jun; 36(2):201-7. PubMed ID: 7406949
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.
Havel RJ; Hunninghake DB; Illingworth DR; Lees RS; Stein EA; Tobert JA; Bacon SR; Bolognese JA; Frost PH; Lamkin GE
Ann Intern Med; 1987 Nov; 107(5):609-15. PubMed ID: 3662274
[TBL] [Abstract][Full Text] [Related]
10. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia.
Bradford RH; Shear CL; Chremos AN; Dujovne C; Downton M; Franklin FA; Gould AL; Hesney M; Higgins J; Hurley DP
Arch Intern Med; 1991 Jan; 151(1):43-9. PubMed ID: 1985608
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia.
Dart A; Jerums G; Nicholson G; d'Emden M; Hamilton-Craig I; Tallis G; Best J; West M; Sullivan D; Bracs P; Black D
Am J Cardiol; 1997 Jul; 80(1):39-44. PubMed ID: 9205017
[TBL] [Abstract][Full Text] [Related]
12. Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study.
Dujovne CA; Bays H; Davidson MH; Knopp R; Hunninghake DB; Stein EA; Goldberg AC; Jones P; Lipka LJ; Cuffie-Jackson C
J Clin Pharmacol; 2001 Jan; 41(1):70-8. PubMed ID: 11144997
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies.
Hunninghake DB
Am J Cardiol; 1998 Aug; 82(4B):26J-31J. PubMed ID: 9737643
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia.
Yu WC; Chen CH; Tsao HM; Ding YA
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):260-7. PubMed ID: 12201566
[TBL] [Abstract][Full Text] [Related]
15. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia.
Bradford RH; Shear CL; Chremos AN; Franklin FA; Nash DT; Hurley DP; Dujovne CA; Pool JL; Schnaper H; Hesney M
Am J Med; 1991 Jul; 91(1B):18S-24S. PubMed ID: 1867232
[TBL] [Abstract][Full Text] [Related]
16. A multicenter double-blind study comparing lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
Vallés F; Anguita M; Anglada J; Aguirre C; Fabiani F; Plaza L; Soriguer F; Azanza JR; Barcina C
Atherosclerosis; 1991 Dec; 91 Suppl():S3-9. PubMed ID: 1789815
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
[TBL] [Abstract][Full Text] [Related]
18. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864
[TBL] [Abstract][Full Text] [Related]
19. The long-term effects of probucol on serum lipid levels.
McCaughan D
Arch Intern Med; 1981 Oct; 141(11):1428-32. PubMed ID: 7025778
[TBL] [Abstract][Full Text] [Related]
20. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ
Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
